Aquestive Therapeutics (AQST) Accumulated Expenses (2017 - 2026)
Aquestive Therapeutics' Accumulated Expenses was $5.58 million in Q3 2026, up 8.7% from $5.13 million a year earlier and up 23.4% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Aquestive Therapeutics came in at $5.03 million, down 14.9% from FY2024.
- Accumulated Expenses has now declined for four consecutive years, with a five-year compound annual growth rate of -10.1% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $5.91 million in FY2024 (-9.1%), $6.5 million in FY2023 (-18.5%), $7.97 million in FY2022 (-8.8%) and $8.74 million in FY2021 (+1.9%).
- The Q3 2026 figure marks the highest quarterly Accumulated Expenses since Q4 2024.
- Compared with a year earlier, Accumulated Expenses was higher in three of the last eight quarters, with an average decline of 7.4%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2024 (growth of 33.1%); the worst was Q2 2023 (a decline of 39.5%).
- Per Business Quant data, AQST's Accumulated Expenses in the three quarters before Q3 2026 was $4.52 million (Q2 2026), $3.45 million (Q1 2026) and $5.03 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.58 Mn |
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 5.03 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.67 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 5.47 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Dec 31, 2022 | 7.97 Mn |
| Sep 30, 2022 | 7.73 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 4.87 Mn |
| Dec 31, 2021 | 8.74 Mn |
API Access
Aquestive Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();